Recombinant BMP-7 (Bone morphogenetic protein-7), Human ,AF
Source: Human Cytokines Catalog No. : PY2120
Recombinant BMP-7 (Bone morphogenetic protein-7), Human ,AF (PY2120)
UniProt:P18075
Application:Cell culture,Elisa
Endotoxin level:<0.1 EU per 1 μg of the protein by the LAL method.
Gene ID:Human Cytokineshttp://www.abways.cn/showproduct.asp?cid=PY2120
数据表
-
UniProt
-
Gene ID655
-
Calculated Molecular Weight14.00 kDa
-
SDS-PAGE Molecular Weight(under reducing condition)12 kDa
-
Alternative NamesOsteogenic Protein-1 (OP-1)
-
ActivityMeasure by its ability to induce alkaline phosphatase production by ATDC5 cells. The ED50 for this effect is <0.65 μg/mL.
-
StorageLyophilized protein should be stored at -20°C for 1 year. Upon reconstitution, store at 2°C to 8°C for up to 1 week. Further dilute in a buffer containing a carrier protein or stabilizer (e.g. 0.1% BSA, 10%FBS, 5%HSA or 5% trehalose solution), protei
-
Purification>98% as determined by SDS-PAGE. Ni-NTA chromatography
-
Fusion tagHis-tag at the C-terminus
-
Expression HostEscherichia coli
-
DescriptionBMP-7 (Bone morphogenetic protein 7) is a bone morphogenetic protein which belongs to the TGF-β superfamily. OP-1 is expressed in the brain, kidneys, and bladder. BMP-7 may be involved in bone homeostasis and plays a key role in the transformation of mesenchymal cells into bone and cartilage. The phosphorylation of SMAD1 and SMAD5 can be induced by BMP-7, which in turn induce transcription of numerous osteogenic genes. BMP-7 treatment can also induce all of the genetic markers of osteoblast differentiation in many cell types. Human recombinant BMP-7 protein can be used to aid in the fusion of vertebral bodies to prevent neurologic trauma. It also functions in the treatment of tibial non-union, frequently in cases where a bone graft has failed. It is found that BMP7 has the potential for treatment of chronic kidney disease.
-
FormulationThe protein was lyophilized from a 0.2 µm filtered solution containing 20 mM sodium citrate, 0.2 M NaCl, pH 3.5.
-
ReconstitutionIt is recommended to reconstitute the lyophilized protein in sterile H2O to a concentration not less than 100 μg/mL and incubate the stock solution for at least 20 min to ensure sufficient re-dissolved.
Applications
-
Endotoxin level<0.1 EU per 1 μg of the protein by the LAL method.
-
ApplicationCell culture,Elisa
-
Expression SequenceMANVAENSSSDQRQACKKHELYVSFRDLGWQDWIIAPEGYAAYYCEGECAFPLNSYMNATNHAIVQTLVHFINPETVPKPCCAPTQLNAISVLYFDDSSNVILKKYRNMVVRACGCH with polyhistidine tag at the C-terminus.



销售咨询
一键电话